Novo Nordisk Pharmatech A/S is a pharmaceutical company and was established in 1949 as FeF Chemicals. In 1986 FeF Chemicals was acquired by Novo Nordisk, a world leader in diabetes care and a Danish healthcare company. Novo Nordisk Pharmatech has since then been part of the Novo Nordisk pharmaceutical group.
Novo Nordisk Pharmatech A/S is the leading worldwide supplier of products as recombinant insulin for cell growth media and pharmaceutical grade quaternary ammonium compounds (Quats) for the biopharmaceutical and pharmaceutical industries. We improve biopharmaceutical manufacturing by developing and supplying innovative products used in the manufacturing of biopharmaceuticals.
We as a company has attracted the leading pharmaceutical companies through our high product quality, extensive manufacturing and quality control, regulatory documentation, precision delivery and a comprehensive risk mitigation strategy.
Enabling better medicines.
We are committed to providing sustainable pharmaceutical materials through innovative and customised solutions
Novo Nordisk Pharmatech is currently present in the following:
The Novo Nordisk Way is a set of guiding principles which underpins every decision we make. It describes who we are, how we work and what we want to achieve, and sets a clear direction for our company and our employees. Ultimately, it’s a promise we make to each other – and to the millions of patients all over the world who rely on our products to lead full and healthy lives.
In 1923, our Danish founders began a journey to change diabetes. Today, we are thousands of employees across the world with the passion, skills and commitment to drive change to defeat diabetes and other serious chronic diseases.
Every day, we must make difficult choices, always keeping in mind what is best for patients, our employees and our shareholders in the long run.
It’s our way. It’s the Novo Nordisk Way.
Your message has been sent!
An error has occured
Please send us an email at email@example.com